ALK-Abelló A/S (CPH:ALK.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
208.60
-3.60 (-1.70%)
Aug 28, 2026, 4:59 PM CET

ALK-Abelló Revenue

ALK-Abelló had revenue of 1.80B DKK in the quarter ending June 30, 2026, with 17.55% growth. This brings the company's revenue in the last twelve months to 6.83B, up 16.52% year-over-year. In the year 2025, ALK-Abelló had annual revenue of 6.31B with 14.00% growth.

Revenue (ttm)
6.83B
Revenue Growth
+16.52%
P/S Ratio
6.78
Revenue / Employee
2.46M
Employees
2,773
Market Cap
46.28B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.31B775.00M14.00%
Dec 31, 20245.54B713.00M14.78%
Dec 31, 20234.82B313.00M6.94%
Dec 31, 20224.51B595.00M15.19%
Dec 31, 20213.92B425.00M12.17%
Dec 31, 20203.49B217.00M6.63%
Dec 31, 20193.27B359.00M12.32%
Dec 31, 20182.92B5.00M0.17%
Dec 31, 20172.91B-95.00M-3.16%
Dec 31, 20163.01B436.00M16.97%
Dec 31, 20152.57B136.00M5.59%
Dec 31, 20142.43B189.00M8.42%
Dec 31, 20132.24B-101.00M-4.31%
Dec 31, 20122.35B-3.00M-0.13%
Dec 31, 20112.35B189.00M8.75%
Dec 31, 20102.16B224.00M11.58%
Dec 31, 20091.94B151.00M8.46%
Dec 31, 20081.78B132.00M7.99%
Dec 31, 20071.65B133.00M8.76%
Dec 31, 20061.52B30.00M2.01%
Aug 31, 20061.49B272.00M22.35%
Aug 31, 20051.22B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Novo Nordisk329.43B
Coloplast28.44B
Genmab27.03B
H. Lundbeck25.96B
Demant24.63B
GN Store Nord16.46B
Embla Medical6.44B
Bavarian Nordic6.34B
Revenue Rankings